AI Article Synopsis

Article Abstract

Background: Huangqi injection is derived from Astragalus membranaceus root. In China, recent reports of Huangqi injection for the treatment of leucopenia have emerged. However, a systematic review of these reports has not been performed. Thus, we conducted a meta-analysis of clinical controlled trials to assess the clinical value of Huangqi injection in the treatment of leucopenia.

Methods: We searched the Chinese Biomedical Literature Database (CBM), Wanfang Database, China National Knowledge Infrastructure (CNKI), Chinese Scientific Journals Full-text Database (VIP), as well as PubMed and EMBASE to collect the data about trials of Huangqi injection for treating leucopenia. A meta-analysis was performed using RevMan 5.2 software.

Results: A total of 13 studies involving 841 patients were included in this study. The overall study quality was lower according to the Jadad scale. The meta-analysis showed that experimentally treated patients experienced greater therapeutic efficacy and lower white blood cell counts than control groups treated with Western medicine (P < 0.05). No publication bias was evident, according to Egger's test.

Conclusions: The validity of this meta-analysis was limited by the overall poor quality of the included studies. Huangqi injection may have potential clinical value in the treatment of leucopenia, but confirmation with rigorously well-designed multi-center trials is needed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861487PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0083123PLOS

Publication Analysis

Top Keywords

huangqi injection
24
injection treatment
12
treatment leucopenia
12
clinical huangqi
8
leucopenia meta-analysis
8
meta-analysis clinical
8
clinical controlled
8
controlled trials
8
injection
6
clinical
5

Similar Publications

Research on the protective effect of Rhizoma of Anemarrhena asphodeloides on TMT induced AD mice model based on network pharmacology combined with in vitro and in vivo experimental validation.

J Pharmacol Sci

February 2025

Department of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China; Anhui Province Key Laboratory of Traditional Chinese Medicine Decoction Pieces of New Manufacturing Technology, Hefei, 236000, China. Electronic address:

Background: Alzheimer's disease (AD) is a neurodegenerative disease, and neuroprotection is an important approach to improving AD outcomes. Rhizoma of Anemarrhena asphodeloides (RAA) is a commonly used Traditional Chinese Medicine (TCM) with demonstrated neuroprotective effects, but its anti-AD mechanism requires further exploration.

Aim Of The Study: To elucidate the neuroprotective mechanism of RAA on TMT-induced AD mice.

View Article and Find Full Text PDF

Bayesian network Meta-analysis was conducted to assess the efficacy and safety of different Chinese medicine injections for dilated cardiomyopathy(DCM). CNKI, Wanfang, VIP, SinoMed, PubMed, Web of Science, EMbase, Cochrane Library, ProQuest, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov were searched for the randomized controlled trial(RCT) from the inception to January 2024.

View Article and Find Full Text PDF

This study aims to observe the effects of different doses of Astragali Radix on the expression of glucagon(GLP-1) in se-rum and glucagon receptor(GLP-1R) in cartilage tissue in rats with knee osteoarthritis(KOA), explore the effect of Astragali Radix on the inflammation and apoptosis of KOA by regulating GLP-1/GLP-1R signaling axis, and investigate the mechanism of its action in alleviating KOA. Forty-eight male SD rats were randomly divided into six groups: blank group, model group, low-, medium-, and high-dose Astragali Radix groups(3.125, 6.

View Article and Find Full Text PDF
Article Synopsis
  • Astragali radix (AR) is a popular traditional Chinese herbal medicine known for its immunomodulatory and anti-inflammatory effects, although many benefits were previously only shown in lab settings (in vitro).
  • The study aimed to investigate the impact of AR on immune cells and the intestines of mice when taken orally, bridging the gap to real-life effects (in vivo).
  • Results indicated that AR-treated mice had enhanced macrophage response and changes in T cell populations, suggesting AR could modify immune responses, particularly in how inflammation is regulated without increasing certain inflammatory cytokines.
View Article and Find Full Text PDF

Comparison of chemical composition between imitation wild and transplanted Astragali Radix and their therapeutic effects on heart failure.

J Ethnopharmacol

January 2025

Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China; Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Beijing, China; Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Beijing, China. Electronic address:

Article Synopsis
  • Astragali Radix (AR) is a traditional Chinese herbal remedy used for chronic heart failure, with two main types available: 5-year old (5YAR) and 2-year old (2YAR), but their effectiveness needs more research.
  • The study aimed to compare the chemical compositions and protective effects of both types of AR on heart failure, using ethanol extracts in mouse models.
  • Results showed that 5YAR had higher levels of saponins and flavonoids but lower polysaccharides compared to 2YAR, and both types helped prevent heart damage caused by inducing heart failure.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!